1-苯基-2-(4-吡啶)乙酮 | 1620-55-9

• 物质功能分类: 医药中间体 - 吡啶类化合物
• 分子结构分类: 有机化合物 - 有机氧化合物
• 中文名称: 1-苯基-2-(4-吡啶)乙酮
• 中文别名: 1-苯基-2-(吡啶基-4-)乙酮
• 英文名称: 1-phenyl-2-(4-pyridinyl)ethanone
• 英文别名: 4-Phenacyl-pyridin；4-phenacylpyridine；1-phenyl-2-(pyridin-4-yl)ethanone；1-phenyl-2-(4-pyridyl)ethanone；1-phenyl-2-(4-pyridyl)-1-ethanon；1-phenyl-2-pyridin-4-ylethanone
• CAS: 1620-55-9
• 化学式: C₁₃H₁₁NO
• 分子量: 197.236
• InChiKey: ACULMSXMKICJIS-UHFFFAOYSA-N

物化性质

• 熔点：
  100-105 °C
• 沸点：
  350.3±17.0 °C(Predicted)
• 密度：
  1.127±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  15
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.08
• 拓扑面积：
  30
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 海关编码：
  2933399090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 1-Phenyl-2-(pyridin-4-yl)ethanone
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 1-Phenyl-2-(pyridin-4-yl)ethanone
CAS number: 1620-55-9

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C13H11NO
Molecular weight: 197.2

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-苯基-2-(4-吡啶)乙酮 在 [双(三氟乙酰氧基)碘]苯 作用下， 以 二氯甲烷 为溶剂， 反应 48.0h， 以19%的产率得到苯基-吡啶-4-基-乙二酮
  参考文献：
  名称：

  Andrews, Ian P.; Lewis, Norman J.; McKillop, Alexander, Heterocycles, 1994, vol. 38, # 4, p. 713 - 718

  摘要：

  DOI：
• 作为产物：
  描述：

  苯甲腈 在 正丁基锂 、 二异丙胺 、 氢溴酸 作用下， 以 四氢呋喃 、 正己烷 为溶剂， 反应 3.0h， 以90%的产率得到1-苯基-2-(4-吡啶)乙酮
  参考文献：
  名称：

  [EN] PYRAZOLOPYRIDINE DERIVATES
  [FR] DERIVES DE PYRAZOLOPYRIDINE

  摘要：

  公式（I）的新化合物及其盐、溶剂合物和前药，其中各种取代基的含义如描述中所披露的。这些化合物可用作p38激酶抑制剂。

  公开号：

  WO2004076450A1

文献信息

• Proteasome inhibitors and methods of using the same
  申请人：Bernardini Raffaella

  公开号：US20060189806A1

  公开（公告）日：2006-08-24

  The present invention provides boronic acid compounds, boronic esters, and compositions thereof that can modulate apoptosis such as by inhibition of proteasome activity. The compounds and compositions can be used in methods of inducing apoptosis and treating diseases such as cancer and other disorders associated directly or indirectly with proteasome activity.

  本发明提供了硼酸化合物、硼酸酯及其组合物，可以调节细胞凋亡，例如通过抑制蛋白酶体活性。这些化合物和组合物可用于诱导细胞凋亡和治疗癌症等疾病，以及与蛋白酶体活性直接或间接相关的其他疾病。
• Rhodium-catalyzed synthesis of unsymmetric di(heteroaryl) compounds via heteroaryl exchange reactions
  作者：Mieko Arisawa

  DOI：10.1080/10426507.2019.1602621

  日期：2019.7.3

  activities by interacting with proteins and nucleic acids. Then, synthesis of such compounds is critical for the development of drugs. Unsymmetric HetAr-X-HetAr′ compounds were efficiently synthesized by rhodium-catalyzed heteroaryl exchange reactions, which involved equilibrium control by judicious design of organic heteroaryl reagents. This method allows synthesis of unsymmetric HetAr–O–HetAr′, HetAr–S–HetAr′

  摘要 不对称二（杂芳基）HetAr-X-HetAr'化合物具有柔性和刚性基团，有望通过与蛋白质和核酸相互作用而表现出多种生物活性。然后，此类化合物的合成对于药物开发至关重要。不对称 HetAr-X-HetAr' 化合物是通过铑催化的杂芳基交换反应有效合成的，该反应涉及通过有机杂芳基试剂的明智设计来控制平衡。该方法允许从杂芳基芳基醚和杂芳基试剂合成不对称 HetAr-O-HetAr'、HetAr-S-HetAr' 和 HetAr-CH2-HetAr' 化合物以及 HetAr-F 化合物。铑催化的杂芳基交换反应也用于从 N-苯甲酰基杂芳烃和杂芳基芳基醚合成 C-N 连接的二（杂芳基）化合物。该合成具有广泛的适用性，提供了多种新型不对称 HetAr-X-HetAr' 和 C-N 连接的二（杂芳基）化合物，其中含有五元和六元杂芳烃。图形概要
• MEDICINAL COMPOSITIONS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1402900A1

  公开（公告）日：2004-03-31

  The present invention relates to an agent for the prophylaxis or treatment of pain, an agent for suppressing activation of osteoclast, and an inhibitor of osteoclast formation, which contains a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor.

  本发明涉及一种用于预防或治疗疼痛的药剂，一种用于抑制破骨细胞活化的药剂，以及一种包含p38 MAP激酶抑制剂和/或TNF-α产生抑制剂的破骨细胞形成抑制剂。
• CONCOMITANT DRUGS
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP1354603A1

  公开（公告）日：2003-10-22

  The present invention relates to a pharmaceutical agent containing one or more kinds of a p38 MAP kinase inhibitor and/or a TNF-α production inhibitor and one or more kinds of drugs selected from the group consisting of (1) a non-steroidal antiinflammatory drug, (2) a disease-modifying anti-rheumatic drug, (3) an anti-cytokine drug, (4) an immunomodulator, (5) a steroid and (6) a c-Jun N-terminal kinase inhibitor in combination. This combination agent is useful as a prophylactic or therapeutic agent of the diseases such as rheumatism, arthritis and the like, and other diseases.

  本发明涉及一种含有一种或多种p38 MAP激酶抑制剂和/或TNF-α产生抑制剂以及从（1）非甾体抗炎药、（2）疾病修饰性抗风湿药、（3）抗细胞因子药物、（4）免疫调节剂、（5）类固醇和（6）c-Jun N末端激酶抑制剂中选择的一种或多种药物的药物制剂。这种组合药剂可用作预防或治疗风湿病、关节炎等疾病以及其他疾病的药物。
• Regioselective synthesis of 4-(2-oxoalkyl)pyridines via 1,4-dihydro-pyridine derivatives using silyl enol ethers and pyridinium salts
  作者：Kin-ya Akiba、Yoshihiro Nishihara、Makoto Wada

  DOI：10.1016/s0040-4039(00)88414-2

  日期：——

  – 87% yields. When 2, 2, 2-trichloroethyl chloroformate was employed, yields of the corresponding 1,4-dihydropyridines (0 were higher (80 – 100% yields). and were oxidized by oxygen or AgNO3 to give 4-(2-oxoalkyl)pyridines ( : 30 –65%).

  三甲基甲硅烷基烯醇醚（）与1-乙氧基羰基吡啶鎓氯化物（）在4位反应，具有较高的区域选择性，从而得到1-乙氧基羰基-4-（2-氧代烷基）-1,4-二氢吡啶（收率42 – 87％。当2， 2，2-三氯乙酯被使用时，相应的1,4-二氢吡啶的产率（0较高（80 - 100％的产率）。并且通过氧被氧化或硝酸银3，得到4-（2-氧代）吡啶（： 30 –65％）。